(firstQuint)Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar.

 The investigators assessed the efficacy and safety of the ACT in uncomplicated falciparum malaria in different sentinel sites in Myanmar.

 The recruited patients were follow-up until day 28 or day-42 based on the ACTs.

 Day-0 samples were analysed for artemisinin molecular markers, (K13 kelch propeller, Pfmdr2, Pffd and Pfarps10).

.

 Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar@highlight

Efficacy and safety of the artemisinin combination therapy (ACT) in uncomplicated falciparum malaria patients in Myanmar and artemisinin molecular markers analysis